KIT and melanoma: Moreover, CD117- ILCs and CD117+ ILCs from melanoma patients showed impaired TNFα secretion when activated ex vivo with PMA/ionomycin in comparison with ILCs from healthy individuals (Figure 1B), consistent with observations in hematological malignancies (17, 18).